An exploration of current and emerging platforms for gene therapy in HIV cure research. This session contrasts viral and non-viral strategies, from established lentiviral vectors to cutting-edge lipid nanoparticles (LNPs) and extracellular vesicles (EVs). Presentations will include technical considerations, delivery efficiency, and relevance to HIV-specific constraints such as cell targeting and integration site preferences.
This webinar is part of the series Cell and gene therapy for HIV cure: Platforms, progress and practical considerations. Watch webinar 1 here.